Organ-on-a-Chip Market Trends and AI Integration

Answer : The patient monitoring devices market size was surpassed at US$ 36.5 billion in 2021 and is projected to reach around US$ 80.75 billion by 2030 with a CAGR of 8.3% from 2021 to 2030.

Answer : Rise in chronic diseases across the globe especially in the older generation people, increase in older population across the globe and the rapid technological advancement in the patient monitoring devices are the key driving factors for patient monitoring devices market growth.

Answer : The major market player includes in patient monitoring devices market are Abbott Laboratories, Hill-Rom Holdings, Inc., Drägerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, OMRON Corporation, Masimo Corporation, Compumedics Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, Natus Medical, Medtronic plc (Ireland), Koninklijke Philips N.V., GE Healthcare, Getinge AB, Boston Scientific Corporation, Dexcom, Inc., Nonin, BIOTRONIK, SCHILLER, and BioTelemetry, Inc..

Answer : The cardiac monitoring devices segment hold revenue share of 20.1% in 2021 due to increase in cardiovascular disease across the world leading to stroke and heart attack.

Answer : The North America region is expected to lead the market with market share of more than 43.2% in 2021.